TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Total cardiovascular event rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Colony forming units of Escherichia coli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Colony forming units of enterococci
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of bifidobacteria in stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in reading age
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: percentage of patients with residual GSV at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recall of emotionally arousing words
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Aortic Pulse Wave Velocity (PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: At-home consistency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-office success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuation of MUSE therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: long-term mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: hospital mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: 1-year mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: Assistance summoned for abnormal vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recording of parameters on MEWS chart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response (CR) rates for AK I-III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Median maximal pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wake after sleep onset (WASO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Diagnostic event occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: serum α‐carotene levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum β‐carotene levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum lutein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MRI defect filling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional parameters stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of elevated blood lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Height of the dermoepidermal junction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Neutralizing antibodies (Nabs) detection
Endpoint domain: Adverse events/effects
Primary endpoint: Medication prescribing adherence to JNC guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average IOP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year recurrence events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall and nocturnal confirmed hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Cognition improvement measured by ADAS-cog
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in 24-h urinary protein excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Endogenous creatinine clearance rate (Ccr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Serum levels of tuftsin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum levels of IgM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Word recall on Trial 6
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of losses from Trial 3-4
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of gains from Trial 5-6
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Release of EMP from HUVECs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SHSS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in child/youth symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in youth-rated symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absorbed dose to the red marrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median absorbed dose to tumours for MAA(K)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median absorbed dose to tumours for MAA(RM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in HRQOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of watery diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Same-day discharge
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Recall of health behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients with an ACR20 response at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leaving sick-listed and shifting to returned to work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: AUC(0-30 min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(plasma 30 min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of pneumothorax
Endpoint domain: Adverse events/effects
Primary endpoint: Need for treatment due to pneumothorax
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: cavernous arterial peak systolic flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: resistance indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Awareness of the Fresh Empire brand
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: symptoms and functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Δt EMG‐MMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Δt MMG‐F
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: episodes of drunkenness
Endpoint domain: Adverse events/effects
Primary endpoint: intention to get drunk
Endpoint domain: Adverse events/effects
Primary endpoint: alcohol-related problem behaviours
Endpoint domain: Adverse events/effects
Primary endpoint: Mean linear growth velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Significant pain relief (> or =50%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of cure
Endpoint domain: Adverse events/effects
Primary endpoint: Survival of children
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative incidence of death or survival with a neurodevelopmental disability
Endpoint domain: Mortality/survival
Primary endpoint: Tinnitus Functional Index (TFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: A1C reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall confirmed hypoglycemia rates
Endpoint domain: Adverse events/effects
Primary endpoint: mean heart rate changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of treatment-emergent cardiac adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Uptake of isoflurane (AUC of isoflurane blood concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk for ischemic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in disability (MODQ scores)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative arterial oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Plasma HIV-1 RNA daily decay rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decay rate of latently infected cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptomatic urinary tract infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Confidence in managing diagnosable conditions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Confidence in managing general concerns
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Confidence in making necessary referrals
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Absorption rates of suppository and elixir preparations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T(max) and elimination half-life (t(½))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(max) and total drug exposure (AUC(0‐∞))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: USPIO-defined inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of total response (no retching or vomiting, no nausea)
Endpoint domain: Adverse events/effects
Primary endpoint: Eradication percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammatory cell reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: lens epithelial cells (LECs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood-aqueous barrier breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right Ventricular Myocardial Performance Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fatigue level (Borg Scale)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Recurrent HF hospitalizations
Endpoint domain: Mortality/survival
Primary endpoint: First HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Mean induction-to-abortion interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed of response to antipsychotics (PANSS negative symptom subscale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed of response to antipsychotics (total PANSS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of oophorectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of in-utero involution of the cyst
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child fruit intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental fruit intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vRBC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Fat(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain change scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-hernioplasty acute and chronic pain/discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parenteral/oral analgesic consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of daily goal caloric intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum prealbumin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of information delivered
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Chances of stopping smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: antibiotic prescription rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increase in platelet activation parameters (P-selectin and glycoprotein 53)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in PEFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of stay in the ED
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: MSSES Control score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: saline contamination rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pain relief on postoperative day 1
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Numerical Pain Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Roland‐Morris Disability Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of spinal fixations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain reduction (WOMAC A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central and peripheral blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Arterial wave reflection (cAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pathologic complete response (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean menstrual cycle length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean follicular phase length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum hormone-binding globulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Volume on day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term catheter dependency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serial AUA symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean recovery time to a train-of-four ratio greater than 0.7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical and patient outcomes of the HealthTracker-based medication review
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of Computer Vision Syndrome (CVS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for PC-PALs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ratings of computer-specific progressive addition lenses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of sinusitis after zygomatic implant surgery
Endpoint domain: Adverse events/effects
Primary endpoint: step reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: paretic rectus femoris postural reflex onset latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of falls
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in CHW functioning indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in household behaviors (feeding colostrum)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in care-seeking behaviors (treatment of diarrhea with ORS and zinc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical response (complete and partial response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pulmonary function (FEV1, MVV, PEF, FEF50, FEF75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Visual analog scales (VAS) for pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bath ankylosing spondylitis disease active index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advise-Assist knowledge improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General communication skills performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol-specific tasks performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Status Indicator (FSI) related to limitation in stair climbing or moderate activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: cessation of bleeding in one week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accommodative facility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative weight recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in aerobic steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cardiovascular disease
Endpoint domain: Mortality/survival
Primary endpoint: Increase in asthma-like symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in IL-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in IL-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Loss of protective sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities of antioxidant enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: interpersonal behavior outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endorsement of TBI explanation over adolescent explanation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Racial disparities in diabetes control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of free testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Steroid‐binding proteins (SHBG and CBG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total score of WOMAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F2-isoprostanes concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial misalignment of target volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of death or nonfatal infarction
Endpoint domain: Mortality/survival
Primary endpoint: composite neuropsychological RBANS score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: composite of cardiovascular death, myocardial infarction, and stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CM symptoms efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h expulsion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: complete abortion rates at 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean morning and evening peak flows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of spontaneous preterm birth
Endpoint domain: Mortality/survival
Primary endpoint: Night systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HOMA-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in menopausal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital admission or relapse within 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAD total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: JKOM score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: household physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality-Adjusted Life Years (QALY) reduction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cost associated with treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median reduction in Higham score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined amenorrhea/hypomenorrhea rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes